Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
This article was originally published in The Gray Sheet
Executive Summary
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than a more extensive overhaul
You may also be interested in...
FDA Proposes Changes To Advisory Committee Voting Procedures
FDA is proposing that members of its advisory committees vote on issues simultaneously, rather than sequentially, to avoid influencing each other
FDA Proposes Changes To Advisory Committee Voting Procedures
FDA is proposing that members of its advisory committees vote on issues simultaneously, rather than sequentially, to avoid influencing each other
FDA Aims To Up Transparency By Making Panel Materials Public Sooner
FDA will post advisory committee briefing materials on its Web site at least two business days in advance of meetings, doubling the current lead time in an effort to enhance transparency, according to a 1draft guidance released last week